摘要
阻塞性睡眠呼吸暂停低通气综合征(obstructive sleep apnoea, OSA)是一种常见的临床疾病,其特征是慢性间歇性缺氧和睡眠片段化,可导致多器官、多系统功能障碍。OSA可增加阿尔兹海默症(Alzheimer's disease, AD)的风险,同时可导致脂质代谢的异常,而脂质代谢异常也是AD重要的发病机制。从胆固醇代谢、磷脂类代谢、脂蛋白类代谢、载脂蛋白类代谢对OSA的脂质代谢异常的标志物及其可能参与AD的起病及进展进行综述,有助于筛选OSA增加AD风险的早期评估指标,为临床探索生物标志物构建理论依据。
Obstructive sleep apnea(OSA)is a common clinical condition characterized by chronic intermittent hypoxia and sleep fragmentation,which can lead to multi-organ and multi-system dysfunction.Prior research has shown that OSA can increase the risk of Alzheimer's disease(AD),and can also trigger abnormal lipid metabolism,an important pathogenic feature of AD.In this review,we discuss the markers of abnormal lipid metabolism of OSA,discussing the possible involvement of cholesterol,phospholipid,lipoprotein and apolipoprotein metabolism in the onset and progression of Alzheimer's disease.This knowledge will be helpful in the screening of early evaluation indicators of OSA which increase the risk of AD.Further,this knowledge can be used to construct a theoretical basis for the clinical exploration of relevant biomarkers.
作者
王璐
张云云
郭华
崔小川
WANG Lu;ZHANG Yunyun;GUO Hua;CUI Xiaochuan(Department of General Medicine,Affiliated Wuxi People's Hospital of Nanjing Medical University,Wuxi Medical Center,Nanjing Medical University,Wuxi 214023,Jiangsu,China)
出处
《山东大学耳鼻喉眼学报》
CAS
2023年第6期68-74,共7页
Journal of Otolaryngology and Ophthalmology of Shandong University
基金
无锡市卫健委“双百”中青年医疗卫生拔尖人才课题项目(BJ2020008)。
